methazolamide has been researched along with Mast Cell Activation Disease in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henry, EK | 1 |
| Sy, CB | 1 |
| Inclan-Rico, JM | 1 |
| Espinosa, V | 1 |
| Ghanny, SS | 1 |
| Dwyer, DF | 1 |
| Soteropoulos, P | 1 |
| Rivera, A | 1 |
| Siracusa, MC | 1 |
1 other study available for methazolamide and Mast Cell Activation Disease
| Article | Year |
|---|---|
Carbonic anhydrase enzymes regulate mast cell-mediated inflammation.
Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Immunoglobulin E; Inflammation; Mast Ce | 2016 |